Cargando…
Adverse effect signature extraction and prediction for drugs treating COVID-19
Given the considerable cost of drug discovery, drug repurposing is becoming attractive as it can effectively shorten the development timeline and reduce the development cost. However, most existing drug-repurposing methods omitted the heterogeneous health conditions of different COVID-19 patients. I...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673014/ https://www.ncbi.nlm.nih.gov/pubmed/36406131 http://dx.doi.org/10.3389/fgene.2022.1019940 |